| Literature DB >> 25051345 |
Ype de Jong1, Johannes Henricus Francisca Maria Pinckaers1, Robin Marco ten Brinck1, Augustinus Aizo Beent Lycklama à Nijeholt1, Olaf Matthijs Dekkers2.
Abstract
BACKGROUND: It is suggested that the body posture during urination can influence urodynamic parameters in patients with Lower Urinary Tract Symptoms (LUTS) to an extent approaching pharmacological interventions. In this article, the influence of body position during micturition on maximum urinary flow rate (Qmax), voiding time (TQ) and post-void residual volume (PVR) in healthy males and patients with LUTS is analyzed by means of a systematic review and meta-analysis. EVIDENCE ACQUISITION: A systematic search was conducted in 14 medical databases. Studies comparing urodynamic parameters in standing versus sitting position were eligible for inclusion. Studies were stratified according to health status of included male participants: healthy individuals and patients with LUTS. Standardized mean differences for Qmax, TQ and PVR were pooled in a random effects model.Entities:
Mesh:
Year: 2014 PMID: 25051345 PMCID: PMC4106761 DOI: 10.1371/journal.pone.0101320
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1PRISMA flowchart showing the study selection process.
Characteristics of included studies.
| Study source | Participants | Mean difference in sitting versus standing posture (95% CI) |
|
| N = 20, stratified: | Group A: |
| Group A: n = 10 healthy men | Qmax 0.50 (−1.55 to 2.55) | |
| Group B: n = 10 LUTS/BPH patients | TQ −2.50 (−4.79 to 0.21) | |
| PVR n/a | ||
| Group B: | ||
| Qmax 0.20 (−0.92 to 1.32) | ||
| TQ −6.50 (−20.33 to 7.33) | ||
| PVR −63.00 (−96.58 to −29.42) | ||
|
| N = 31 healthy men | Qmax 1.00 (−2.17 to 4.17) |
| TQ −1.80 (−5.65 to 2.05) | ||
|
| N = 61 healthy men | Qmax −4.00 (−5.90 to −2.10) |
| TQ 9.30 (4.84 to 13.76) | ||
| PVR 1.50 (0.04 to 2.96) | ||
|
| N = 200 LUTS/BPH patients | Qmax 0.70 (−0.37 to 1.77) |
| TQ −2.50 (−7.22 to 2.22) | ||
| PVR −13.10 (−24.00 to −2.20) | ||
|
| N = 30 healthy men | Qmax 4.50 (2.04 to 6,96) |
| TQ −1.40 (−3.04 to 0.24) | ||
| PVR −0.20 (−3.35 to 2.95) | ||
|
| N = 110 LUTS/BPH patients, stratified: | Both groups: |
| Group A: N = 44 (alpha blockers) | Qmax 1.80 (0.76 to 2.84) | |
| Group B: N = 66 (control group) | TQ −2.50 (−7.31 to 2.31) | |
| PVR −3.40 (−18.71 to 11.91) | ||
|
| N = 20 LUTS/BPH patients | Qmax −0.55 (−1.08 to −0.02) |
| TQ −0.38 (−1.48 to 0.72) | ||
|
| N = 100 LUTS/BPH patients | Both groups: |
| Qmax 5.90 (5.12 to 6.68) | ||
| PVR −55.70 (−70.47 to −40.93) | ||
|
| N = 88, stratified: | Group A: |
| Group A: N = 44 (healthy men) | Qmax 0.50 (−1.04 to 2.04) | |
| Group B: N = 44 (LUTS/BPH patients) | PVR −1.20 (−3.38 to 0.98) | |
| Group B: | ||
| Qmax −0.70 (−1.72 to 0.32) | ||
| PVR 3.30 (−19.80 to 26.40) | ||
|
| N = 36 healthy men | Qmax 0.71 (−0.64 to 2.06) |
| PVR 0.60 (−1.33 to 2.53) | ||
|
| N = 21 healthy men | Qmax −2.10 (−5.77 to 1.57) |
Characteristics of included studies for the difference between the urodynamic parameters: maximum urinary flow rate (ml/s, Qmax), voiding time (s, TQ), and post-void residual volume (ml, PVR) in the sitting versus standing position in healthy males and male patients with Lower Urinary Tract Symptoms (LUTS).
Risk of bias assessment.
| Exposure determination | Assessment of outcomes | Standardization of voiding conditions | ||||||||||
| Age | LUTS-symtoms | PVR | TBC | Other >measurements | Setting | Circadian rhythm | Ejaculation | Defecation | IAP | Preferred position | ||
|
|
| Yes | Clinical | Yes | Yes | Yes | Clinical and private‡ | No | No | No | Yes | No |
|
| Yes | Clinical and IPSS | Yes | No | Yes | Clinical and private‡ | Yes | No | No | No | No | |
|
| Yes | Clinical | NA† | NA† | Yes | Home | No | No | Yes | No | Yes | |
|
| Yes | No | Yes | Yes | Yes | No | No | No | No | Yes | No | |
|
|
| Yes | Clinical | No | No | Yes | No | No | No | No | No | No |
|
| Yes | IPSS | Yes | No | Yes | Clinical and private‡ | No | No | No | Yes | No | |
|
|
| Yes | NA* | NA† | NA† | Yes | Clinical and private‡ | No | No | No | No | No |
|
| Yes | NA* | Yes | No | Yes | No | Yes | No | No | No | Yes | |
|
| Yes | NA* | Yes | No | Yes | Clinical and private‡ | Yes | No | No | Yes | No | |
|
| Yes | NA* | Yes | No | Yes | Clinical and private‡ | No | No | No | Yes | No | |
|
| Yes | NA* | NA† | NA† | Yes | Clinical and private‡ | No | No | No | Yes | No | |
Assessment of the risk of bias in individual studies based on (1) exposure determination which includes standardization of age and assessment of LUTS severity by IPSS questionnaires, (2) assessment of study outcomes, which concerns standardization of measurements and (3) standardization of voiding conditions, including the influence of the setting, circadian rhythm, time since last ejaculation and defecation, and instructions about intra-abdominal pressure. LUTS: Lower Urinary Tract Symptoms, PVR: Post-void residual volume, TBC: Total bladder capacity, IAP: intra-abdominal pressure, IPSS: International Prostate System Score. *No LUTS patients were included in this study. †No PVR measurements and subsequently total bladder capacity measurements were performed in this study. ‡Measurements took place in a private setting, i.e. out of sight and hearing range of researchers.
Figure 2Forest plot from random effects meta-analysis on the difference in maximum urinary flow rate (Qmax) in both healthy males and male patients with Lower Urinary Tract Symptoms (LUTS) in the sitting versus standing position.
Figure 4Forest plot from random effects meta-analysis on the difference in post-void residual volume (PVR) in both healthy males and male patients with Lower Urinary Tract Symptoms (LUTS) in the sitting versus standing position.